- Home
- LGCB vs CYCN Comparison
LGCB vs CYCN Comparison
Compare LGCB & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- CYCN
- Stock Information
- Founded
- LGCB 2011
- CYCN 2018
- Country
- LGCB Japan
- CYCN United States
- Employees
- LGCB N/A
- CYCN N/A
- Industry
- LGCB
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- LGCB
- CYCN Health Care
- Exchange
- LGCB Nasdaq
- CYCN Nasdaq
- Market Cap
- LGCB 8.4M
- CYCN 7.5M
- IPO Year
- LGCB 2023
- CYCN N/A
- Fundamental
- Price
- LGCB $0.14
- CYCN $2.60
- Analyst Decision
- LGCB
- CYCN
- Analyst Count
- LGCB 0
- CYCN 0
- Target Price
- LGCB N/A
- CYCN N/A
- AVG Volume (30 Days)
- LGCB 572.6K
- CYCN 31.9K
- Earning Date
- LGCB 04-08-2025
- CYCN 03-04-2025
- Dividend Yield
- LGCB N/A
- CYCN N/A
- EPS Growth
- LGCB N/A
- CYCN N/A
- EPS
- LGCB N/A
- CYCN N/A
- Revenue
- LGCB $10,289,681.00
- CYCN $2,000,000.00
- Revenue This Year
- LGCB N/A
- CYCN N/A
- Revenue Next Year
- LGCB N/A
- CYCN N/A
- P/E Ratio
- LGCB N/A
- CYCN N/A
- Revenue Growth
- LGCB N/A
- CYCN N/A
- 52 Week Low
- LGCB $0.15
- CYCN $1.27
- 52 Week High
- LGCB $5.71
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- LGCB 25.50
- CYCN 47.88
- Support Level
- LGCB $0.15
- CYCN $2.44
- Resistance Level
- LGCB $0.17
- CYCN $2.68
- Average True Range (ATR)
- LGCB 0.02
- CYCN 0.20
- MACD
- LGCB -0.00
- CYCN 0.02
- Stochastic Oscillator
- LGCB 15.38
- CYCN 39.83
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.